Evidence map›Paper›PMID 24074032›Full record

ArticleBiochemistry2013

Splicing kinase SRPK1 conforms to the landscape of its SR protein substrate.

Brandon E Aubol, Michael A Jamros, Maria L McGlone, Joseph A Adams

Abstract read
In one paragraph

Article in Biochemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Vitamin D receptor and RXR in the post-genomic era.Journal of cellular physiology · 2015
    Review
  10. Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Brandon E AubolDepartment of Pharmacology, University of California-San Diego , La Jolla, California 92093-0636, United States.
Michael A Jamros
Maria L McGlone
Joseph A Adams
University of California, San Diego · US

Funding

GRADUATE TRAINING IN CELLULAR &MOLECULAR PHARMACOLOGYT32GM007752 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROWN, JOAN HELLER, HANDEL, TRACY M · 1985 to 2023
$13.5M
Role of protein phosphorylation in RNA splicingR01GM067969 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ADAMS, JOSEPH · 2004 to 2024
$6.4M
Clk Kinases and Splicing RegulationR01GM098528 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ADAMS, JOSEPH · 2012 to 2019
$2.5M
NIGMS NIH HHS GM67969NIGMS NIH HHS GM98528NIGMS NIH HHS R01 GM067969NIGMS NIH HHS R01 GM098528NIGMS NIH HHS T32 GM007752
6 · The paper itself

Abstract

The splicing function of SR proteins is regulated by multisite phosphorylation of their C-terminal RS (arginine-serine rich) domains. SRPK1 has been shown to phosphorylate the prototype SR protein SRSF1 using a directional mechanism in which 11 serines flanked by arginines are sequentially fed from a docking groove in the large lobe of the kinase domain to the active site. Although this process is expected to operate on lengthy arginine-serine repeats (≥8), many SR proteins contain smaller repeats of only 1-4 dipeptides, raising the question of how alternate RS domain configurations are phosphorylated. To address this, we studied a splice variant of Tra2β that contains a C-terminal RS domain with short arginine-serine repeats [Tra2β(ΔN)]. We showed that SRPK1 selectively phosphorylates several serines near the C-terminus of the RS domain. SRPK1 uses a distributive mechanism for Tra2β(ΔN) where the rate-limiting step is the dissociation of the protein substrate rather than nucleotide exchange as in the case of SRSF1. Although a functioning docking groove is required for efficient SRSF1 phosphorylation, this conserved structural element is dispensable for Tra2β(ΔN) phosphorylation. These large shifts in mechanism are likely to account for the slower net turnover rate of Tra2β(ΔN) compared to SRSF1 and may signal fundamental differences in phosphorylation among SR proteins with distinctive arginine-serine profiles. Overall, these data indicate that SRPK1 conforms to changes in RS domain architecture using a flexible kinetic mechanism and selective usage of a conserved docking groove.

Indexed as

Models, MolecularAmino Acid MotifsArginineHumansKineticsMolecular Docking SimulationMutant ProteinsNerve Tissue ProteinsNuclear ProteinsPhosphorylationProtein ConformationProtein Interaction Domains and MotifsProtein IsoformsProtein Processing, Post-TranslationalProtein Serine-Threonine KinasesProtein StabilityArginineClk dual-specificity kinasesMutant ProteinsNerve Tissue ProteinsNuclear ProteinsProtein IsoformsProtein Serine-Threonine KinasesProtein-Tyrosine KinasesRecombinant ProteinsRNA-Binding ProteinsSerineSerine-Arginine Splicing FactorsSRPK1 protein, humanTRA2B protein, human

Identifiers

PMID24074032
PMCPMC3865722
OpenAlexW1971975779

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.